CLINICAL CURATIVE EFFECT OF CYTOKINES COMBINED WITH DOSE-VOLUME HISTOGRAM PARAMETERS AND FEATURES IN PREDICTING RADIATION-INDUCED LUNG INJURY FOR NON-SMALL CELL LUNG CANCER

被引:1
|
作者
Chu, Li [1 ]
Yao, Xuepin [1 ]
Duan, Yingxin [1 ]
机构
[1] Xingtai Med Coll, Dept Radiotherapy & Chemotherapy, Affiliated Hosp 2, Xingtai 054000, Hebei, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2022年 / 38卷 / 04期
关键词
Cytokines; Dose-Volume Histogram Parameters; Non-Small Cell Lung Cancer; Radiation-Induced Lung Injury; Predictive Value; RADIOTHERAPY; PNEUMONITIS; IL-6;
D O I
10.19193/0393-6384_2022_4_404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aimed to investigate the clinical features of patients with non-small cell lung cancer (NSCLC), the levels of interleukin-1 (IL-1), interleukinn-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) in plasma before and after radiotherapy. Methods: The correlation between dose-volume histogram (DVH) parameters and radiation-induced lung injury (RILI) was also studied. The clinical data of 200 patients with locally advanced NSCLC who received three-dimensional conformal radiotherapy (3D-CRT) in the hospital were retrospectively studied. These patients were divided into an occurrence group and a non-occurrence group. Enzyme-linked immunosorbent assay (ELISA) was adopted for detecting IL-1, IL-6, and TNF-alpha in plasma before and during radiotherapy. V 5, V 10, V 15, V 20, and mean lung dose (MLD) parameters were obtained from DVH, then the correlations between cytokines and DVH parameters as well as RILI were analyzed. Result: The incidence of RILI was 30.5%, and the incidence of RILI with abnormal lung function before radiotherapy was 49.1%, which was higher than 25.5% in patients with normal lung function. IL- 6 level in patients with RILI before radiotherapy was higher than that in the non-occurrence group. The V 5, V 10, and MLD in patients with RILI were higher than those in the non-occurrence group. Conclusion: Multivariate analysis showed that IL-6, V 5, and V 10 were independent risk factors for RILI before radiotherapy. The IL-6 level combined with V 5 and V 10 had a good predictive effect on RILI in patients with NSCLC before radiotherapy.
引用
收藏
页码:2697 / 2704
页数:8
相关论文
共 50 条
  • [41] Radiation-induced tumor immunity in patients with non-small cell lung cancer
    Lockney, Natalie A.
    Zhang, Mei
    Morris, Christopher G.
    Nichols, Romaine Charles
    Okunieff, Paul
    Swarts, Steven
    Zhang, Zhenhuan
    Zhang, Bingrong
    Zhang, Amy
    Hoppe, Bradford S.
    THORACIC CANCER, 2019, 10 (07) : 1605 - 1611
  • [42] Clinical Characteristics and Dose Volume Histogram Parameters Associated With Pleural Effusion in Non-Small Cell Lung Cancer Patients Treated With Chemoradiation Therapy
    Deek, M. P.
    Nagarajan, S.
    Kim, S.
    Ahmed, I.
    Paul, S.
    Scher, E. D.
    Listo, M.
    Chen, A.
    Aisner, J.
    Hussain, S.
    Haffty, B. G.
    Jabbour, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E412 - E412
  • [43] Tagrisso Induced Lung Injury in Non-Small Cell Lung Cancer
    Iftikhar, A.
    Adial, A.
    Cheema, M.
    Singh, H.
    Trivedi, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [44] Risk factors for radiation-induced lung injury in patients with advanced non-small cell lung cancer: implication for treatment strategies
    Sha Sha
    Jigang Dong
    Maoyu Wang
    Ziyu Chen
    Peng Gao
    World Journal of Surgical Oncology, 19
  • [45] Risk factors for radiation-induced lung injury in patients with advanced non-small cell lung cancer: implication for treatment strategies
    Sha, Sha
    Dong, Jigang
    Wang, Maoyu
    Chen, Ziyu
    Gao, Peng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [46] Radiation dose effect in locally advanced non-small cell lung cancer
    Kong, Feng-Ming
    Zhao, Jing
    Wang, Jingbo
    Faivre-Finn, Corrine
    JOURNAL OF THORACIC DISEASE, 2014, 6 (04) : 336 - 347
  • [47] Predictive effect of cytokines in non-small cell lung cancer
    Huber, R. M.
    Stump, J.
    Reu, S.
    Jiang, Y.
    Karches, C.
    Gosalvez, J. S.
    Neumann, J.
    Kobold, S.
    Tufman, A.
    Hatz, R.
    Winter, H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Dose-volume Comparison of Proton Radiotherapy and Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer
    Kadoya, N.
    Kato, T.
    Suzuki, M.
    Kagiya, M.
    Saito, T.
    Nakamura, T.
    Tomoda, T.
    Takada, A.
    Fuwa, N.
    Obata, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S135 - S135
  • [49] Prediction of Distant Metastasis Using Dose-Volume Metrics in Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy
    Diamant, A. A.
    Seuntjens, J.
    El Naqa, I.
    Al-Halabi, H.
    Adil, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E603 - E603
  • [50] Mean Lung Dose Correlates with Volume of Radiation-Induced Lung Injury in Patients Treated with SABR for Lung Cancer
    Killean, A. J.
    Ramaesh, R.
    Turnbull, R.
    Nailon, W. H.
    McLaren, D. B.
    Phillips, I. D.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S209 - S210